The Trade Alliance to Promote Prosperity has created several editorial cartoons for newspapers, social media influencers, and bloggers to use when discussing drug pricing policies, specifically to educate about the perils of importing socialist pricing policies…
Read MoreApril 26 will be World Intellectual Property (IP) Day, the annual celebration of intellectual property rights. In new infographics, TAPP highlights the value of U.S. IP protections, noting their role in driving domestic innovation and maintaining a strong position globally…
Read MoreThe Trade Alliance to Promote Prosperity penned a letter to the editor of the Pike County Courier to praise U.S. Rep. Rob Bresnahan (PA-08) for his stance on drug price reforms…
Read MoreTrade Alliance to Promote Prosperity Executive Director Kent Kaiser, Ph.D., penned an op-ed for the DC Journal, “Reject Trump’s ‘Most Favored Nation’ Drug Pricing Idea, published today…
Read MoreThe Trade Alliance to Promote Prosperity recently responded to “Request for Comments on Section 301 Investigations of Acts, Policies, and Practices of Various Economies Related to the Failure to Impose and Effectively Enforce a Prohibition on the Importation of Goods Produced with Forced Labor” posted by the U.S. Trade Representative on the agency’s comments portal…
Read MoreThe Trade Alliance to Promote Prosperity is a signatory on a letter from a coalition of 18 organizations to the U.S. Trade Representative and the U.S. Ambassador to Japan, urging the Trump administration to address deeply destructive regulations and price controls on the biopharmaceutical sector during upcoming discussions with Japanese Prime Minister Sanae Takaichi…
Read MoreThe Trade Alliance to Promote Prosperity today urged the U.S. House Energy and Commerce Committee to urge Congress to examine misaligned incentives in the 340B drug pricing program as part of the committee’s hearing on “Lowering Health Care Costs for All Americans: An Examination of the U.S. Provider Landscape.”…
Read MoreThe Trade Alliance to Promote Prosperity joined a coalition of 16 organizations in writing a letter to President Trump, condemning foreign actions against U.S. technology leaders…
Read MoreTrade Alliance to Promote Prosperity Executive Director Kent Kaiser, Ph.D., and American Edge Project CEO Doug Kelly penned an op-ed, "America's AI Future Requires Massive Infrastructure Investment…
Read MoreIn response to a Health Resources and Services Administration Request for Information in the Federal Register, the Trade Alliance to Promote Prosperity today submitted comments supporting a proposed 340B rebate model pilot program…
Read MoreThe Trade Alliance to Promote Prosperity joined more than 40 organizations in urging Congress to eliminate the Center for Medicare and Medicaid Innovation (CMMI) because of its terrible rate of success in delivering lower drug prices or higher quality for patients…
Read MoreThe Trade Alliance to Promote Prosperity has submitted comments requesting that the Centers for Medicare & Medicaid Services (CMS) withdraw the proposed GUARD Model prescription drug payment scheme…
Read MoreThe Trade Alliance to Promote Prosperity has submitted comments requesting that the Centers for Medicare & Medicaid Services (CMS) withdraw the proposed GLOBE Model prescription drug payment scheme…
Read MoreThe Trade Alliance to Promote Prosperity filed an e-Allegation with U.S. Customs and Border Patrol pursuant to the organization’s 2025 Tariff Integrity initiative case study about Techtronic Industries/Milwaukee Tool. Subsequently, CBP confirmed that an enforcement action came of it and thanked TAPP for helping to protect the U.S. economy…
Read MoreThe Trade Alliance to Promote Prosperity joined more than 50 other signers in writing to Congress, urging opposition to codifying President Trump’s most favored nation drug pricing policy, saying it would “import socialist price controls and values into our country”…
Read MoreThe Inflation Reduction Act subjects “large-molecule” biologic therapies to price controls 13 years after FDA approval, but "small-molecule" medicines are subject to price controls after only 9 years. This lack of parity between small molecules and biologics is undermining patient care by limiting access to affordable drugs…
Read MoreThe Trade Alliance to Promote Prosperity has an op-ed, "Stop Letting the World Freeload Off American Patients," appearing in the DC Journal today…
Read MoreThe Trade Alliance to Promote Prosperity recently signed onto a letter from a coalition of 30+ organizations to Federal Housing Finance Agency Director William Pulte, urging caution in the implementation of new mortgage credit scoring rules…
Read MoreAccording to reports, the U.S. Department of Commerce is expected to begin tariff reviews in March that could lead to the termination of anti-dumping and countervailing duties imposed in 2021 on certain phosphate fertilizer imports from Morocco and Russia. TAPP supports the review and encourages lifting the tariffs for the benefit of American farmers and grocery consumers…
Read MoreIn anticipation of U.S. House Energy & Commerce and U.S. House Ways & Means Committee hearings with the CEOs of major insurance companies in the United States, the Trade Alliance to Promote Prosperity wrote a letter to urge accountability, clarity, and affordability…
Read More